Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilma Barcellini

Showing results (21-30 of 251) with videos related to

Pageof 26
Sort By:
Expert Opinion on Pharmacotherapy|December 1, 2023
Novel pharmacotherapy for drug-induced immune hemolytic anemiaWilma Barcellini, Bruno Fattizzo
Frontiers in Immunology|July 14, 2020
The Changing Landscape of Autoimmune Hemolytic AnemiaWilma Barcellini, Bruno Fattizzo
Haematologica|October 2, 2014
Treatment of autoimmune hemolytic anemiasAlberto Zanella, Wilma Barcellini
Blood|January 29, 2021
How I treat warm autoimmune hemolytic anemiaWilma Barcellini, Bruno Fattizzo
Blood|July 24, 2020
Management of pyruvate kinase deficiency in children and adultsRachael F Grace, Wilma Barcellini
Thrombosis Journal|September 13, 2022
Correction: Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumoniaAlessandro Bosi, Wilma Barcellini, Bruno Fattizo
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Hematological and Extra-Hematological Autoimmune Complications after Checkpoint InhibitorsBruno Fattizzo, Nicolò Rampi, Wilma Barcellini
Blood Reviews|April 7, 2023
Vaccinations in hematological patients in the era of target therapies: Lesson learnt from SARS-CoV-2Bruno Fattizzo, Nicolò Rampi, Wilma Barcellini
Expert Review of Clinical Immunology|September 12, 2018
Current and emerging treatment options for autoimmune hemolytic anemiaWilma Barcellini, Bruno Fattizzo, Anna Zaninoni
Thrombosis Journal|August 23, 2022
Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumoniaAlessandro Bosi, Wilma Barcellini, Bruno Fattizzo
Pageof 26

Showing results (21-30 of 251) with videos related to

Sort By:
Pageof 26
Expert Opinion on Pharmacotherapy|December 1, 2023
Novel pharmacotherapy for drug-induced immune hemolytic anemiaWilma Barcellini, Bruno Fattizzo
Frontiers in Immunology|July 14, 2020
The Changing Landscape of Autoimmune Hemolytic AnemiaWilma Barcellini, Bruno Fattizzo
Haematologica|October 2, 2014
Treatment of autoimmune hemolytic anemiasAlberto Zanella, Wilma Barcellini
Blood|January 29, 2021
How I treat warm autoimmune hemolytic anemiaWilma Barcellini, Bruno Fattizzo
Blood|July 24, 2020
Management of pyruvate kinase deficiency in children and adultsRachael F Grace, Wilma Barcellini
Thrombosis Journal|September 13, 2022
Correction: Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumoniaAlessandro Bosi, Wilma Barcellini, Bruno Fattizo
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Hematological and Extra-Hematological Autoimmune Complications after Checkpoint InhibitorsBruno Fattizzo, Nicolò Rampi, Wilma Barcellini
Blood Reviews|April 7, 2023
Vaccinations in hematological patients in the era of target therapies: Lesson learnt from SARS-CoV-2Bruno Fattizzo, Nicolò Rampi, Wilma Barcellini
Expert Review of Clinical Immunology|September 12, 2018
Current and emerging treatment options for autoimmune hemolytic anemiaWilma Barcellini, Bruno Fattizzo, Anna Zaninoni
Thrombosis Journal|August 23, 2022
Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumoniaAlessandro Bosi, Wilma Barcellini, Bruno Fattizzo
Pageof 26